Research Paper Volume 12, Issue 7 pp 5792—5811

Decitabine in combination with low-dose cytarabine, aclarubicin and G-CSF tends to improve prognosis in elderly patients with high-risk AML

Figure 3. Kaplan–Meier curves associated with overall survival within age arms (60-66 vs 67-74 vs ≥ 75 years).